Q: May I have your comments on earnings please. Is it buy here?
5i Research Answer:
EPS of 60c beat estimates of 54c; revenue of $457.8M beat estimates by 4.5%. EBITDA of $252.7M missed by 1%. Revenue rose 16%. All divisions did well, but derivatives were the standout, up 22%. The dividend was raised 9%. The stock is at a 52 week low, but this quarter was fine and we would be comfortable buying.